Company / Current Assets per Share
Theravance Biopharma, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$8.46
FY2025
5-year range
$2.05 / $8.46
FY2021-FY2025
Trend
+152.6%
vs FY2024
Sector context
#88 of 210
Health Care
What the data says
At $8.46, Theravance Biopharma, Inc.'s current assets per share ranks #88 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $2.05 in FY2023 to $13.91 in FY2016.
Based on SEC 10-K filings.
8.46 in FY2025 with a 5-year CAGR of +4.2%.
Improved from $2.05 to $8.46 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +21.2%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
#88 of 210 in Health CareTop 42% of 210This company $8.46 Sector average $170.65
▼
-95.0% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 152.6% year-over-year.
- Ranks #88 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2016.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.46 | +152.6% |
| FY2024 | $3.35 | +63.6% |
| FY2023 | $2.05 | -56.9% |
| FY2022 | $4.75 | +22.3% |
| FY2021 | $3.88 | -43.7% |
| FY2020 | $6.90 | +13.5% |
| FY2019 | $6.08 | -38.0% |
| FY2018 | $9.80 | +36.7% |
| FY2017 | $7.17 | -48.5% |
| FY2016 | $13.91 | +88.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026